In vitro immune modulation by antibodies coupled to tumour cells.
Modification of autologous tumour cells to express the immune costimulator B7.1 is a potential strategy for immunotherapy of cancer. Previously, this has involved introduction of genetic material into cells, in vitro culture, and confirmation of the protein product on the cell surface. This is possi...
Asıl Yazarlar: | Darling, D, Galea-Lauri, J, Gäken, J, Towner, P, Kuiper, M, Hollingsworth, S, Hirst, W, Barnard, A, Buggins, A, Mufti, G, Farzaneh, F |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1997
|
Benzer Materyaller
-
Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
Yazar:: Gaken, J, ve diğerleri
Baskı/Yayın Bilgisi: (1997) -
Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
Yazar:: Hirst, W, ve diğerleri
Baskı/Yayın Bilgisi: (1996) -
Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Yazar:: Gaken, J, ve diğerleri
Baskı/Yayın Bilgisi: (1997) -
Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
Yazar:: GaleaLauri, J, ve diğerleri
Baskı/Yayın Bilgisi: (1996) -
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Yazar:: Chan, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)